EDITORIAL SECTION

Articles

Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus

Paracelsus in the th century established the principle of toxicology that the dose of a medicinal defines the difference between a remedy and a toxic effect

The Impact of Digital Health Technologies on Patient Outcomes

It is also noteworthy that the structure of the healthcare system has shifted rather dynamically in the past few years primarily because of the integration of digital health solutions Such developments

Business Transformation Strategies for the Pharmaceutical Industry

The pharmaceutical industry is at a crossroads Drug development timelines remain long regulatory scrutiny keeps intensifying and patients now expect the same seamless digital experiences they get from banking apps or online retailers Against this backdrop pharma business transformation has moved from a nicetohave to a survival requirement

Leveraging Blockchain for Drug Traceability and Security in Europe

The area of interest in the pharmaceutical products in the past couple of years has been in the area of traceability and security Recently there has been an increase in fake drugs as well as advanced supply chain management making it difficult to tell the actual quality of the manufactured drugs

10 Effective Strategies to Reduce Water Waste in Pharmaceutical Manufacturing

Water is a resource of great concern to pharmaceutical manufacturing since it is essential in the cleaning of equipment used in manufacturing operations as well as in drug formulations Nevertheless the pharmaceutical industry presents another leading water consumer and therefore reduction of water wastes should be at the top of the agenda regarding sustainability

Biopharma M&A and Licensing: Strategic Partnerships Fueling Innovation

For much of the last decade acquisitions and licensing agreements were debated in European boardrooms as rival answers to the same question how to refill a pipeline faster than internal research alone allows That framing no longer holds In the most effective pharmaceutical companies run both instruments in parallel choosing between them asset by asset according to scientific maturity geographic o...

Techno Trends

Juniper Biosciences Secures FDA Breakthrough Designation

The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC

Projects

Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion

Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys